How US pressure is endangering India’s access to affordable medicines
In late April, the United States Trade Representative—the agency responsible for developing and recommending US trade policy to the president—released its annual report, called “Special 301.” The report analyses trade policies of countries across the world, especially their intellectual-property laws, and categorises them. India has been put on what the report calls a “priority watch list,” which includes countries judged by the USTR as having “serious intellectual property rights deficiencies” that require the agency’s increased attention. India has been put on the list for a record twenty-seventh time, and is accompanied by ten other countries, including Russia and China. The agency warns: “For such countries that fail to address U.S. concerns, USTR will take appropriate actions … pursuant to World Trade Organization or other trade agreement dispute settlement procedures, necessary to combat unfair trade practices and to ensure that trading partners follow through with their international commitments.”
The reason for India’s seemingly permanent position on the list is its patent system, which the agency deems too lax. According to the report, the main challenges in India for US companies are the country’s patent laws and “counterfeit” medicines. However, these patent laws also help keep prices of medicines low, which has allowed the Indian generic-drugs industry to flourish, ensuring greater access to medicines for not just India, but other developing countries as well. The USTR report is clearly giving voice to the US’s big pharmaceutical companies, which continuously complain about losing revenue in India due to the presence of the generic-drugs industry. Unfortunately, India has already succumbed to US pressure on this issue to a great degree, and further compromise is likely to be against the interest of the Indian masses.
Bu hikaye The Caravan dergisinin June 2019 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye The Caravan dergisinin June 2019 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Mob Mentality
How the Modi government fuels a dangerous vigilantism
RIP TIDES
Shahidul Alam’s exploration of Bangladeshi photography and activism
Trickle-down Effect
Nepal–India tensions have advanced from the diplomatic level to the public sphere
Editor's Pick
ON 23 SEPTEMBER 1950, the diplomat Ralph Bunche, seen here addressing the 1965 Selma to Montgomery March, was awarded the Nobel Peace Prize. The first black Nobel laureate, Bunche was awarded the prize for his efforts in ending the 1948 Arab–Israeli War.
Shades of The Grey
A Pune bakery rejects the rigid binaries of everyday life / Gender
Scorched Hearths
A photographer-nurse recalls the Delhi violence
Licence to Kill
A photojournalist’s account of documenting the Delhi violence
CRIME AND PREJUDICE
The BJP and Delhi Police’s hand in the Delhi violence
Bled Dry
How India exploits health workers
The Bookshelf: The Man Who Learnt To Fly But Could Not Land
This 2013 novel, newly translated, follows the trajectory of its protagonist, KTN Kottoor.